Best Diagnostic Stocks for January 2026: Narayana Hrudayalaya, Fortis Healthcare and More – Based on 1-Year Return

India’s diagnostics and healthcare services sector continues to see steady growth, supported by rising healthcare awareness, increasing insurance penetration, and sustained demand for specialised medical services across urban and semi-urban regions.

Structural factors such as ageing demographics, higher lifestyle-related illnesses, and expansion of hospital and diagnostic networks have contributed to consistent performance across listed healthcare companies.

Let’s look at the best diagnostic stocks for January 2026, ranked based on key parameters such as 1-year return, return on equity, ROCE, debt-to-equity ratio, and net profit margin.

Best Diagnostic Stocks for January 2026 – 1-Year Return Basis

Note: The list of best diagnostic stocks for January 2026 above is ranked based on their 1-year return. Data is as of January 9, 2026.

Overview of the Best Diagnostic Stocks for January 2026

1. Narayana Hrudayalaya Ltd

Narayana Hrudayalaya operates a network of multi-speciality and tertiary care hospitals, with a focus on affordable healthcare delivery across India and overseas markets.

Key Metrics:

• ROCE: 18.14%
• ROE: 24.26%

2. Healthcare Global Enterprises Ltd

Healthcare Global Enterprises is primarily engaged in oncology care, offering specialised cancer treatment services across multiple centres in India.

Key Metrics:

• ROCE: 8.48%
• ROE: 4.79%

3. Fortis Healthcare Ltd

Fortis Healthcare operates hospitals and diagnostic facilities, providing tertiary and quaternary healthcare services across major Indian cities.

Key Metrics:

• ROCE: 10.12%
• ROE: 8.74%

4. Dr. Agarwal’s Health Care Ltd

Dr. Agarwal’s Health Care specialises in eye care services, including diagnostics, surgeries, and vision correction procedures. The company operates through a hub-and-spoke model across several cities.

Key Metrics:

ROCE: 8.63%

ROE: 5.05%

Aster DM Healthcare Ltd

Aster DM Healthcare operates hospitals and clinics across India and the Middle East, offering multi-speciality healthcare services. The company has exposure to both domestic and international healthcare markets.

Key Metrics:

• ROCE: 99.19%
• ROE: 123.89%

Best Diagnostic Stocks for January 2026 Based on Net Profit Margin

Note: The above list is ranked based on net profit margin. Data is as of January 9, 2026.

Best Diagnostic Stocks for January 2026 by Debt-to-Equity Ratio

Note: The above list is ranked based on debt-to-equity ratio. Data is as of January 9, 2026.

Read More: Best Semiconductor Stocks for January 2026: BEL, CG Power and More – Based on 5-Yr CAGR.

Conclusion

This article presents a comparative view of selected diagnostic and healthcare stocks based on financial indicators such as 1-year return, profitability ratios and leverage levels. These metrics are shared for informational purposes only. Investors are advised to evaluate their financial goals, risk appetite and investment horizon, and consult a qualified financial advisor before making any investment decisions.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.